On September 12th, bio-cigarette technology company 22nd Century Group released a statement announcing that its VLN low-nicotine cigarettes are now available for sale in over 1,200 pharmacies across Texas, Florida, Illinois, North Carolina, and Georgia.
According to sources, VLN is the first and only combustible cigarette to be authorized by the FDA and labeled as a reduced harm tobacco product.
John Miller, interim CEO of 22nd Century Group, stated in a declaration that VLN offers a clinically researched novel solution that can assist adult smokers in reducing their smoking habits and mitigating the associated risks brought about by smoking over time.
According to Miller, although most over-the-counter methods for quitting smoking or reducing tobacco consumption are widely unpopular, over 75% of VLN users have stated their satisfaction with the product's experience. After using VLN, 80% of adult consumers have claimed a decrease in their usage of traditional tobacco brands.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
